Cost-effectiveness of treatments for dysfunctional uterine bleeding

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 51, Issue 7, 2006, Pages 553-562

  Wade, Sally W ^b   Magee, Glenn ^a   Metz, Laurent ^b   Broder, Michael S ^b  

^a ETHICON INC   (United States)

^b NONE

Author keywords

Bleeding; Cost effectiveness; Uterus

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSIS RELATED GROUP; FEMALE; HEALTH CARE COST; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; METRORRHAGIA; ORAL CONTRACEPTION; PRIORITY JOURNAL; UTERUS BLEEDING;

ADULT; CATHETER ABLATION; CONTRACEPTIVES, ORAL; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; HYSTERECTOMY; METRORRHAGIA; MIDDLE AGED; MODELS, THEORETICAL;

EID: 33746237711     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. American College of Obstetricians and Gynecologists: Management of anovulatory bleeding. Washington, DC, ACOG, 2001
2. Astrup K, Olivarius NF, Moller S, et al: Menstrual bleeding patterns in pre- and perimenopausal women: A population-based prospective diary study. Acta Obstet Gynecol Scand 2004;83:197-202
3. Prentice A: Health care implications of dysfunctional uterine bleeding. Baillieres Best Pract Res Clin Obstet Gynaecol 1999;13:181-188
4. Cote I, Jacobs P, Cumming DC: Use of health services associated with increased menstrual loss in the United States. Am J Obstet Gynecol 2003;188:343-348
5. Grant C, Gallier L, Fahey T, et al: Management of menorrhagia in primary care: Impact on referral and hysterectomy: Data from the Somerset Morbidity Project. J Epidemiol Community Health 2000;54:709-713
6. Chapple A: Menorrhagia: Women's perceptions of this condition and its treatment. J Adv Nurs 1999;29:1500-1506
7. Broder MS, Kanouse DE, Mittman BS, et al: The appropriateness of recommendations for hysterectomy. Obstet Gynecol 2000;95:199-205
8. Henshaw R, Coyle C, Low S, et al: A retrospective cohort study comparing microwave endometrial ablation with levonorgestrel-releasing intrauterine device in the management of heavy menstrual bleeding. Aust N Z J Obstet Gynaecol 2002;42:205-209
9. Davis A, Godwin A, Lippman J, et al: Triphasic norgestimateethinyl estradiol for treating dysfunctional uterine bleeding. Obstet Gynecol 2000;96:913-920
10. Crosignani PG, Vercellini P, Mosconi P, et al: Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstet Gynecol 1997;90:257-263
11. Higham JM, O'Brien PM, Shaw RW: Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990;97:734-739
12. Chiou CF, Trussell J, Reyes E, et al: Economic analysis of contraceptives for women. Contraception 2003;68:3-10
13. Ortho-McNeil Pharmaceutical: Ortho-Novum tablets (norethindrone/ethinyl estradiol) package insert. Raritan, New Jersey, OMP. Available at: http://www.orthomcneil.com/products/pi/pdfs/orthonov.pdf. Accessed April 14, 2004
14. London R, Holzman M, Rubin D, et al: Payer cost savings with endometrial ablation therapy. Am J Manag Care 1999;5:889-897
15. Brumsted JR, Blackman JA, Badger GJ, et al: Hysteroscopy versus hysterectomy for the treatment of abnormal uterine bleeding: A comparison of cost. Fertil Steril 1996;65:310-316
16. Brooks PG, Clouse J, Morris LS: Hysterectomy vs. resectoscopic endometrial ablation for the control of abnormal uterine bleeding: A cost-comparative study. J Reprod Med 1994;39:755-760
17. Ransom SB, McNeeley SG, White C, et al: A cost analysis of endometrial ablation, abdominal hysterectomy, vaginal hysterectomy, and laparoscopic- assisted vaginal hysterectomy in the treatment of primary menorrhagia. J Am Assoc Gynecol Laparosc 1996;4:29-32
18. Dorsey JH, Holtz PM, Griffiths RI, et al: Costs and charges associated with three alternative techniques of hysterectomy. N Engl J Med 1996;335:476-482
19. Kennedy AD, Sculpher MJ, Coulter A, et al: Effects of decision aids for menorrhagia on treatment choices, health outcomes, and costs: A randomized controlled trial. JAMA 2002;288:2701-2708
20. Cote I, Jacobs P, Cumming D: Work loss associated with increased menstrual loss in the United States. Obstet Gynecol 2002;100:683-687
21. Gath D, Rose N, Bond A, et al: Hysterectomy and psychiatric disorder: Are the levels of psychiatric morbidity falling? Psychol Med 1995;25:277-283
22. Wright B, Gannon MJ, Greenberg M, et al: Psychiatric morbidity following endometrial ablation and its association with genuine menorrhagia. Br J Obstet Gynaecol 2003;110:358-363
23. Jones GL, Kennedy SH, Jenkinson C: Health-related quality of life measurement in women with common benign gynecologic conditions: A systematic review. Am J Obstet Gynecol 2002;187:501-511
24. Shaw RW, Brickley MR, Evans L, et al: Perceptions of women on the impact of menorrhagia on their health using multi-attribute utility assessment. Br J Obstet Gynaecol 1998;105:1155-1159
25. Hurskainen R, Aalto AM, Teperi J, et al: Psychosocial and other characteristics of women complaining of menorrhagia, with and without actual increased menstrual blood loss. Br J Obstet Gynaecol 2001;108:281-285
26. Shapley M, Jordan K, Croft PR: Increased vaginal bleeding: The reasons women give for consulting primary care. J Obstet Gynaecol 2003;23:48-50
27. Munro MG: Endometrial ablation with a thermal balloon: The first 10 years. J Am Assoc Gynecol Laparosc 2004;11:8-22
28. Cooper KG, Parkin DE, Garratt AM, et al: Two-year follow-up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: Clinical and quality of life outcomes. Br J Obstet Gynaecol 1999;106:258-265
29. Cooper KG, Jack SA, Parkin DE, et al: Five-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: Clinical and quality of life outcomes. Br J Obstet Gynaecol 2001;108:1222-1228
30. Nagele F, Rubinger T, Magos A: Why do women choose endometrial ablation rather than hysterectomy? Fertil Steril 1998;69:1063-1066
31. Summitt RL Jr, Stovall TG, Lipscomb GH, et al: Randomized comparison of laparoscopy-assisted vaginal hysterectomy with standard vaginal hysterectomy in an outpatient setting. Obstet Gynecol 1992;80:895-901
32. Hidlebaugh DA: Cost and quality-of-life issues associated with different surgical therapies for the treatment of abnormal uterine bleeding. Obstet Gynecol Clin North Am 2000;27:451-465
33. Grant AM, Bhattacharya S, Mollison J, et al: A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: Outcome at four years: Aberdeen Endometrial Ablation Trials Group. Br J Obstet Gynaecol 1999;106:360-366
34. Duleba AJ, Heppard MC, Soderstrom RM, et al: A randomized study comparing endometrial cryoablation and rollerball electroablation for treatment of dysfunctional uterine bleeding. J Am Assoc Gynecol Laparosc 2003;10:17-26
35. Hawe J, Abbott J, Hunter D, et al: A randomised controlled trial comparing the Cavaterm endometrial ablation system with the Nd:YAG laser for the treatment of dysfunctional uterine bleeding. Br J Obstet Gynaecol 2003;110:350-357
36. Bhattacharya S, Cameron IM, Parkin DE, et al: A pragmatic randomized comparison of transcervical resection of the endometrium with endometrial laser ablation for the treatment of menorrhagia. Br J Obstet Gynaecol 1997;104:601-607
37. Loffer FD: Three-year comparison of thermal balloon and rollerball ablation in treatment of menorrhagia. J Am Assoc Gynecol Laparosc 2001;8:48-54
38. Cooper J, Gimpelson R, Laberge P, et al: A randomized, multicenter trial of safety and efficacy of the NovaSure system in the treatment of menorrhagia. J Am Assoc Gynecol Laparosc 2002;9:418-428
39. Meyer WR, Walsh BW, Grainger DA, et al: Thermal balloon and rollerball ablation to treat menorrhagia: A multicenter comparison. Obstet Gynecol 1998;92:98-103
40. Erian J: Endometrial ablation in the treatment of menorrhagia. Br J Obstet Gynaecol (suppl 11) 1994;101:19-22
41. A Scottish audit of hysteroscopic surgery for menorrhagia: Complications and follow up. Scottish Hysteroscopy Audit Group. Br J Obstet Gynaecol 1995;102:249-254
42. Lissak A, Fruchter O, Mashiach S, et al: Immediate versus delayed treatment of perimenopausal bleeding due to benign causes by balloon thermal ablation. J Am Assoc Gynecol Laparosc 1999;6:145-150
43. Cooper KG, Bain C, Parkin DE: Comparison of microwave endometrial ablation and transcervical resection of the endometrium for treatment of heavy menstrual loss: A randomised trial. Lancet 1999;354:1859-1863
44. Sculpher MJ, Bryan S, Dwyer N, et al: An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. Br J Obstet Gynaecol 1993;100:244-252
45. Zupi E, Zullo F, Marconi D, et al: Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: A prospective randomized trial. Am J Obstet Gynecol 2003;188:7-12
46. Pooley AS, Ewen SP, Sutton CJ: Does transcervical resection of the endometrium for menorrhagia really avoid hysterectomy? Life table analysis of a large series. J Am Assoc Gynecol Laparosc 1998;5:229-235
47. Soysal M, Soysal S, Ozer S: A randomized controlled trial of levonorgestrel releasing IUD and thermal balloon ablation in the treatment of menorrhagia. Zentralbl Gynakol 2002;124:213-219
48. Istre O, Trolle B: Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection. Fertil Steril 2001;76:304-309